发明申请
- 专利标题: ANTI-MISUSE MICROPARTICULATE ORAL DRUG FORM
- 专利标题(中): 抗微生物口服药物形式
-
申请号: US12560044申请日: 2009-09-15
-
公开(公告)号: US20100266701A1公开(公告)日: 2010-10-21
- 发明人: Florence Guimberteau , Remi Meyrueix , Gerard Soula
- 申请人: Florence Guimberteau , Remi Meyrueix , Gerard Soula
- 申请人地址: FR Venissieux Cedex
- 专利权人: Flamel Technologies, S.A.
- 当前专利权人: Flamel Technologies, S.A.
- 当前专利权人地址: FR Venissieux Cedex
- 优先权: FRFR0550364 20050208; FRFR0551344 20050524
- 主分类号: A61K9/14
- IPC分类号: A61K9/14 ; A61K31/52 ; A61K31/155
摘要:
The invention relates to solid microparticulate oral dosage forms having a composition that prevents the misuse of the active pharmaceutical ingredient (API) contained therein. The aim of the invention is to prevent the improper use of solid oral drugs for any use other than the therapeutic use(s) officially approved by the appropriate public health authorities. Another aim of the invention is to provide novel analgesic drugs which can be used to: prevent the misuse of, and addiction to certain analgesics and/or to control plasma concentration variability and/or to facilitate oral; administration; and/or to combine analgesics with one another and/or with one or more active ingredients in the same oral form. More specifically, the invention relates to a solid oral drug form comprising anti-misuse means and at least one active ingredient, which is characterized in that: at least part of the active ingredient is contained in microparticles; and the anti-misuse means comprise anti-crushing means (a) which enable the microparticles of the active ingredient to resist crushing, such as to prevent the misuse thereof. According to the invention, the drug form can also comprise means (b) for preventing the misuse of the active ingredient following a possible liquid extraction process.
信息查询